SCGB2A1 and endometrial cancer: Additionally, another study identified a a panel of fivegenes (ASRGL1, RHEX, SCGB2A1, SOX17, and STX18) as biomarkers for predicting lymph node metastasis in early-stage endometrial cancer patients (28).